Brief: Trinity Biotech Announces Q2 2023 Results
03/10/2023 14:24
Oct 3 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES Q2 2023 FINANCIAL RESULTS
* TRINITY BIOTECH PLC - REVENUE OUTLOOK FOR Q3 IS EXPECTED
TO BE
APPROXIMATELY $14M TO $15M
* TRINITY BIOTECH PLC- QTRLY BASIC LOSS PER ADS WAS $0.16
Source text for Eikon: ID:nGNX3TCPqk
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM